nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo journalinfonormal searchdiv searchzone qikanlogo popupnotification paper paperNew
2020, 01, v.48;No.231 31-34
叶酸辅助治疗对伴高同型半胱氨酸血症高血压患者颈动脉硬化的影响
基金项目(Foundation): 云浮市医学科研项目(项目编号:2017B41)
邮箱(Email):
DOI:
发布时间: 2020-02-15
出版时间: 2020-02-15
移动端阅读
摘要:

目的:观察叶酸辅助治疗对伴高同型半胱氨酸(Hcy)血症高血压患者颈动脉硬化的影响。方法:选取我院2018年1月至2019年5月收治的80例伴高Hcy血症高血压患者,完全随机分4组,每组各20例。对照组给予常规基础治疗,高剂量组、中剂量组、低剂量组分别在常规基础治疗同时给予相应剂量叶酸辅助治疗,比较4组治疗前后血压、血浆Hcy、一氧化氮(NO)水平及颈动脉硬化程度[内中膜厚度(IMT)与斑块Crouse积分]。"结果:治疗后,高剂量组收缩压、舒张压、Hcy水平、颈动脉IMT、斑块Crouse积分明显低于中剂量组、低剂量组、对照组(P<0.05),中剂量组、低剂量组明显低于对照组(P<005);高剂量组NO水平明显高于中剂量组、低剂量组、对照组(P<0.05),中剂量组、低剂量组明显高于对照组(P<0.05)。结论:叶酸辅助疗法,尤其选择高剂量叶酸,可有效降低伴高Hcy血症高血压患者血压、Hcy水平,提高NO水平,改善颈动脉硬化情况。

Abstract:

Objective:To investigate the effect of adjuvant therapy with folic acid on carotid arteriosclerosis in hypertensive patients with with hyperhomocysteinemia.Methods:A total of 80 hypertensive patients with hyperhomocysteinemia treated in our hospital between January 2018 and May 2019 were randomly divided into 4 groups(n= 20 each). The control group was given conventional care,and in addition to this,the high-dose,medium-dose and low-dose folic acid groups were given adjuvant therapy with corresponding dose of folic acid.The blood pressure,plasma hyperhomocysteine(Hcy)and nitric oxide(NO)levels,and carotid arteriosclerosis[intima-media thickness(IMT)and Crouse's plaque score]were compared between the 4 groups before and after treatment.Results:After treatment,the systolic and diastolic blood pressures,Hcy level,carotid IMT,and Crouse's plaque score were significantly lower in the high-dose group than those in the medium-dose group,lowdose group,and control group(P<0.05),and were significantly lower in the medium-dose and low-dose groups than those in the control group(P<0.05). The NO level was significantly higher in the high-dose group than that in the medium-dose group,the low-dose group,and the control group(P<0.05),and was significantly higher in the medium-dose and low-dose groups than that in the control group(P<0.05).Conclusion:Adjuvant therapy with folic therapy,particulary at high doses,can effectively reduce blood pressure and Hcy levels,increase NO levels,and improve carotid arteriosclerosis in hypertensive patients with hyperhomocysteinemia.

参考文献

[1]卫聪颖,赵连友,李雪,等.马来酸依那普利叶酸片治疗H型高血压疗效及其与同型半胱氨酸关系研究[J].中国实用内科杂志,2015,35(7):606-609.

[2]赵江阳,李海炜,王健,等.高血压患者高Hcy血症与FA、VitB12、SOD的相关性研究[J].广西医科大学学报,2015,32(2):262-264.

[3]李鸿飞,王丹璐.依那普利叶酸片对H型高血压伴血压晨峰患者干预效果研究[J].实用心脑肺血管病杂志,2016,24(S1):26-28.

[4]霍岩.丹红注射液联合叶酸片对高同型半胱氨酸血症型高血压患者人血浆同型半胱氨酸的影响[J].辽宁中医杂志,2017,44(2):297-298.

[5]骆高江,季宁宁,倪市毛.马来酸依那普利叶酸治疗H型高血压93例[J].医药导报,2015,34(3):335-338.

[6]中国高血压防治指南修订委员会.中国高血压防治指南(2010年修订版)[J].中国实用乡村医生杂志,2012,19(12):l-15.

[7]黄羽.马来酸依那普利叶酸片联合亚低温对伴H型高血压缺血性脑卒中患者血管内皮功能、神经功能缺损及预后的影响[J].医学临床研究,2018,35(2):284-287.

[8]张仪坚,刘德丽,宋丽娟.依那普利叶酸片对H型高血压伴左心室肥厚患者血浆同型半胱氨酸及心功能的影响[J].解放军医药杂志,2017,29(04):56-59.

[9]彭慧,陈苏,王四坤,等.叶酸联合VitB 12治疗对高血压合并高同型半胱氨酸血症患者血生化指标及颈动脉硬化的影响[J].海南医学院学报,2016,22(18):2205-2208.

[10]唐岚,周礼清,王人佩,等.叶酸联合维生素B6对老年H型高血压患者高同型半胱氨酸血症的疗效观察[J].山西医药杂志,2016,45(4):445-447.

[11]柏平,朱江,姚艳林,等.同型半胱氨酸、叶酸及维生素B12对高血压及其合并症的临床价值[J].检验医学,2017,32(1):41-44.

[12]罗羽慧,封杰,崔坤,等.马来酸依那普利叶酸片治疗短暂性脑缺血发作伴H型高血压的临床研究[J].中国药房,2017,28(2):222-224.

[13]李芳,郝玉明,祖秀光,等.伴高同型半胱氨酸的老年女性高血压急症患者叶酸治疗的5年预后[J].中华老年心脑血管病杂志,2015,17(1):49-52.

[14]李刚.叶酸联合维生素B12对高血压伴高同型半胱氨酸血症患者颈动脉硬化的影响[J].中华高血压杂志,2015,23(2):182-184.

基本信息:

中图分类号:R544.1;R589.3

引用信息:

[1]陈伟君,黄国飞,叶金汉,等.叶酸辅助治疗对伴高同型半胱氨酸血症高血压患者颈动脉硬化的影响[J].广州医科大学学报,2020,48(01):31-34.

基金信息:

云浮市医学科研项目(项目编号:2017B41)

发布时间:

2020-02-15

出版时间:

2020-02-15

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文